Ticker Scorecard - WGS Basics Company: GeneDx Holdings Corp. IPO Date: November 2, 2020 Sector: Healthcare Industry: Health Information Services Market Cap: $2.69B Activated in VL: True Average Daily Range Avg Daily Range: $0.93 | 5.03% Avg Daily Range (30 D): $4.36 | 5.42% Avg Daily Range (90 D): $3.12 | 4.11% Institutional Daily Volume Avg Daily Volume: .79M Avg Daily Volume (30 D): 1.17M Avg Daily Volume (90 D): .76M Trade Size Avg Trade Size (Sh.): 121 Avg Trade Size (Sh.) (30 D): 51 Avg Trade Size (Sh.) (90 D): 49 Institutional Trades Total Inst.Trades: 404 Avg Inst. Trade: $2.22M Avg Inst. Trade (30 D): $2.64M Avg Inst. Trade (90 D): $2.44M Avg Inst. Trade Volume: .05M Avg Inst. Trades (Per Day): 2 Market Closing Trades Avg Closing Trade: $2.78M Avg Closing Trade (30 D): $5.13M Avg Closing Trade (90 D): $3.49M Avg Closing Volume: 56.62K     News Feb 18, 2025 @ 8:50 PM GeneDx Stock Was up 2,700% in 2024 — Can It... Source: Valuewalk Nov 16, 2024 @ 9:54 AM Meet the Healthcare Stock That Produced Nvidia-Siz... Source: Cory Renauer Nov 3, 2024 @ 2:28 PM Apple Satellite Connectivity Provider Globalstar A... Source: Lekha Gupta Jul 19, 2024 @ 11:12 PM Opko Health sells $823k of GeneDx holdings shares ... Source: Investing.Com Jul 17, 2024 @ 5:01 PM Expert Ratings For GeneDx Hldgs - Benzinga Source: Benzinga Insights, Benzinga Staff Writer Financials   TTM Q2 2024 Q1 2024 Basic EPS $-.31 $-1.1 $-.78 Diluted EPS $-.31 $-1.1 $-.78 Revenue $ 76.87M $ 70.51M $ 62.42M Gross Profit $ 47.83M $ 42.95M $ 37.41M Net Income / Loss $ -8.31M $ -29.17M $ -20.24M Operating Income / Loss $ -7.78M $ -10.58M $ -13.66M Cost of Revenue $ 29.05M $ 27.56M $ 25.01M Net Cash Flow $ 1.82M $ -27.6M $ -16.01M PE Ratio     Splits May 04, 2023:   33:1